The Surgical Management of Medullary Thyroid Cancer

被引：16
|
作者：
Dackiw, Alan P. B. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Div Endocrine & Oncol Surg, Dept Surg,Sect Endocrine Surg,Johns Hopkins Hosp, Baltimore, MD 21287 USA
来源：
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA | 2010年 / 43卷 / 02期
关键词：
Medullary thyroid cancer; Treatment guidelines; Evidence-based treatment; Surgical techniques; DNA testing; Prognosis; Thyroidectomy; ENDOCRINE NEOPLASIA TYPE-2A; PROGNOSTIC-FACTORS; CARCINOMA; REOPERATION; RECURRENT; METASTASES; PERSISTENT; GUIDELINES; STRATEGY; STAGE;
D O I：
10.1016/j.otc.2010.01.006
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
Medullary thyroid cancer (MTC), accounts for approximately 5% to 10% of all thyroid cancers. Significant advances in the understanding of the biology and clinical outcomes of MTC have been made over the last decade, culminating most recently in the publication of treatment guidelines by the American Thyroid Association that follow an evidence-based approach that is summarized in this presentation. Prognosis, genetic testing, surgical technique, and re-operation are also discussed.
引用
收藏
页码：365 / +
页数：11
相关论文
共 50 条
  • [31] Medullary thyroid microcarcinoma
    Kazaure, Hadiza S.
    Roman, Sanziana A.
    Sosa, Julie A.
    CANCER, 2012, 118 (03) : 620 - 627
  • [32] Carcinoembryonic antigen should be concurrently checked with calcitonin to identify distant metastases in medullary thyroid cancer
    Zheng-Pywell, Rui
    Cherian, Anish Jacob
    Enman, Macie
    Chen, Herbert
    Abraham, Deepak
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2020, 7 (01)
  • [33] Guideline Adherence and Practice Patterns in the Management of Medullary Thyroid Cancer
    Frisco, Nicholas A.
    Gunn, Alexander H.
    Wang, Frances
    Stang, Michael T.
    Kazaure, Hadiza S.
    Scheri, Randall P.
    JOURNAL OF SURGICAL RESEARCH, 2023, 281 : 214 - 222
  • [34] The surgical treatment of medullary thyroid carcinoma
    Evans, DB
    Fleming, JB
    Lee, JE
    Cote, G
    Gagel, RF
    SEMINARS IN SURGICAL ONCOLOGY, 1999, 16 (01): : 50 - 63
  • [35] Surgical Management of Cervical Lymph Nodes in Differentiated Thyroid Cancer
    Fritze, Danielle
    Doherty, Gerard M.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2010, 43 (02) : 285 - +
  • [36] Medical Management of Metastatic Medullary Thyroid Cancer
    Maxwell, Jessica E.
    Sherman, Scott K.
    O'Dorisio, Thomas M.
    Howe, James R.
    CANCER, 2014, 120 (21) : 3287 - 3301
  • [37] Advances in the management of hereditary medullary thyroid cancer
    Machens, A
    Ukkat, J
    Brauckhoff, M
    Gimm, O
    Dralle, H
    JOURNAL OF INTERNAL MEDICINE, 2005, 257 (01) : 50 - 59
  • [38] Role of vandetanib in the management of medullary thyroid cancer
    Brassard, Maryse
    Rondeau, Genevieve
    BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 59 - 66
  • [39] Ultrasonography features of medullary thyroid cancer as predictors of its biological behavior
    Kim, Cherry
    Baek, Jung Hwan
    Ha, Eunju
    Lee, Jeong Hyun
    Choi, Young Jun
    Song, Dong Eun
    Kim, Jae Kyun
    Chung, Ki-Wook
    Kim, Won Bae
    Shong, Young Kee
    ACTA RADIOLOGICA, 2017, 58 (04) : 414 - 422
  • [40] American Thyroid Association Guidelines for Management of Medullary Thyroid Cancer: An Adult Endocrinology Perspective
    Ball, Douglas W.
    THYROID, 2009, 19 (06) : 547 - 550
12345